Acute Lung Injury clinical trials at UC Davis

1 research study open to eligible people

Showing trials for

  • Mesenchymal Stromal Cells For Acute Respiratory Distress Syndrome

    open to eligible people ages 18 years and up

    This is a Phase 2b, randomized, double-blind, placebo-controlled, multi-center study to assess the safety and efficacy of a single dose of Allogeneic Bone Marrow-derived Human Mesenchymal Stromal Cells (hMSCs) infusion in patients with Acute Respiratory Distress Syndrome (ARDS). This study is the extension of the Phase 1 pilot study (NCT01775774) and Phase 2a study (NCT02097641).

    Sacramento, California and other locations